ELISA Market

What Impact Will Personalized Medicine Have on the ELISA Market s Growth to $32.69 Billion by 2031?

ELISA Market- 2024-2031 Meticulous Research , a global leader in market research, has published an extensive report titled ELISA market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive), Offering (Analyzer, Software), Technology (Chemiluminescence, Colorimetry, Fluorescence), Application (Research, Diagnostic) End User Global Forecast to 2031. This report sheds light on the enzyme-linked immunosorbent assay (ELISA) market's growth, projecting it to reach $32.69 billion by 2031, with a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. Request For Sample Report: https://www.meticulousresearch.com/request-sample- report/cp_id=5997? The growing prevalence of chronic and infectious diseases, advancements in ELISA technology, and the rising use of ELISA in clinical diagnostics and the food industry are driving the market s expansion. However, challenges such as the possibility of false positives and the high cost of ELISA antibody preparation limit the market s potential growth. Market Growth Drivers and Challenges The increasing burden of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, has boosted the demand for diagnostic tools like ELISA. Additionally, advancements in ELISA technology have improved the test s sensitivity and reliability, leading to its widespread use in both research and clinical settings. In the food industry, ELISA is used to detect allergens and other contaminants, further contributing to its growing adoption. Opportunities in the ELISA market includes the rising emphasis on biomarker detection, vaccine development, and increasing research activities in developing countries. However, stringent regulations surrounding the use of alternative diagnostic technologies present a significant challenge for the market s growth. Competitive Landscape The ELISA market is competitive, with several leading players vying for market share. Some of the major players include: Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio- Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioM rieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.). Market Segmentation: By Type The ELISA market is segmented into Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA. Among these, the Indirect ELISA segment is expected to dominate the Page 1 of 3 Meticulous Research| sales@meticulousresearch.com

ELISA Market- 2024-2031 market, accounting for 43.5% of the overall market share in 2024. This method is widely used due to its high sensitivity, making it ideal for diagnosing diseases such as HIV and Lyme disease. Additionally, indirect ELISA is more cost-effective, requiring fewer labeled antibodies compared to other methods. By Offering In terms of offerings, the ELISA market includes Kits & Assays, Analyzers (which are further classified by mode and type), and Software. The Kits & Assays segment is projected to hold the largest share, accounting for 85.2% of the market in 2024. The rising demand for consumables, driven by increasing R&D activities in drug discovery and biomarker detection, underpins the dominance of this segment. By Technology The ELISA market is also categorized by technology into Chemiluminescence ELISA, Colorimetric ELISA, and Fluorescence ELISA. Among these, the Colorimetric ELISA segment is anticipated to account for the largest share in 2024. This method is preferred due to its simplicity, low sample consumption, and affordability. Furthermore, colorimetric absorbance technology is highly effective for the quantification of pure protein samples, contributing to its wide adoption in research and small laboratories. By Application ELISA finds applications in Research, Diagnostics, Food Testing, and Other Applications. In 2024, the Diagnostic Applications segment is expected to lead the market. ELISA is increasingly utilized for diagnosing infectious diseases, allergies, cancer, and autoimmune disorders. The growing incidence of cancer, with cases projected to rise to 32.6 million by 2045, further drives the demand for ELISA in clinical diagnostics. By End User The end-user landscape for ELISA includes Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Contract Development and Manufacturing Organizations (CDMOs), Academic & Research Institutes, and Food Laboratories. Among these, Diagnostic Laboratories are expected to hold the largest market share in 2024, owing to the rising prevalence of chronic diseases and the increasing number of diagnostic laboratories worldwide. Geographic Analysis Geographically, the ELISA market is analyzed across key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is projected to account for the largest share of 37.7% in 2024, driven by advanced healthcare Page 2 of 3 Meticulous Research| sales@meticulousresearch.com

ELISA Market- 2024-2031 infrastructure, significant R&D spending, and the presence of leading market players. Additionally, the expansion of research and clinical laboratories in the region contributes to North America s dominance. For example, in 2022, Thermo Fisher Scientific expanded its clinical research lab in Kentucky, U.S., with a $59 million investment. Conclusion The ELISA market is set to witness substantial growth through 2031, fueled by technological advancements, rising healthcare needs, and expanding applications across various industries. Although challenges such as regulatory hurdles and the risk of false-positive results persist, the market s future appears promising, with significant opportunities for players to capitalize on innovations and emerging applications. Buy Now: https://www.meticulousresearch.com/Checkout/88327546? About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com